GOLDMAN SACHS GROUP INC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$155,693
-29.8%
66,821
-28.3%
0.00%
Q2 2023$221,804
+452.5%
93,195
+327.2%
0.00%
Q1 2023$40,143
+0.4%
21,817
+15.7%
0.00%
Q3 2022$40,000
-33.3%
18,851
-10.4%
0.00%
Q2 2022$60,000
-96.2%
21,039
-94.4%
0.00%
Q1 2022$1,566,000
+96.7%
375,514
+144.8%
0.00%
Q4 2021$796,000
+115.7%
153,421
+172.1%
0.00%
Q3 2021$369,000
-91.5%
56,391
-91.3%
0.00%
-100.0%
Q2 2021$4,319,000
+6443.9%
650,496
+5559.4%
0.00%
Q1 2021$66,000
-48.8%
11,494
-20.1%
0.00%
Q4 2020$129,000
-59.8%
14,385
-47.8%
0.00%
Q3 2020$321,000
-42.2%
27,574
-20.4%
0.00%
Q2 2020$555,000
+141.3%
34,632
-9.8%
0.00%
Q1 2020$230,000
+63.1%
38,388
+258.2%
0.00%
Q4 2019$141,000
-52.7%
10,716
-55.4%
0.00%
Q3 2019$298,000
+8.8%
24,011
+175.4%
0.00%
Q1 2019$274,000
+24.5%
8,720
+30.3%
0.00%
Q4 2018$220,0006,6940.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders